T. Rowe Price Investment Management Inc. Sells 405,864 Shares of The Cooper Companies, Inc. $COO

Key Points

• T. Rowe Price Investment Management Inc. reduced its holdings in The Cooper Companies, Inc. by 5.3%, selling 405,864 shares and now owns approximately 3.64% of the company, valued at $613 million.
• Cooper Companies recently reported $1 billion in revenue with an earnings per share (EPS) of $0.96, exceeding analysts' expectations of $0.93.
• Wall Street analysts generally hold a positive outlook on Cooper Companies, with a consensus rating of "Moderate Buy" and an average price target of $96.73.

T. Rowe Price Investment Management Inc. decreased its holdings in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 5.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 7,273,101 shares of the medical device company's stock after selling 405,864 shares during the period. T. Rowe Price Investment Management Inc. owned approximately 3.64% of Cooper Companies worth $613,487,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Zions Bancorporation National Association UT bought a new position in shares of Cooper Companies in the 1st quarter valued at $33,000. City Holding Co. bought a new stake in Cooper Companies during the 1st quarter worth $34,000. GKV Capital Management Co. Inc. bought a new stake in Cooper Companies during the 1st quarter worth $40,000. Larson Financial Group LLC grew its position in Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after acquiring an additional 664 shares during the last quarter. Finally, HM Payson & Co. grew its position in Cooper Companies by 147.4% during the 1st quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock worth $75,000 after acquiring an additional 532 shares during the last quarter. Institutional investors own 24.39% of the company's stock.

Cooper Companies Stock Up 0.7%

Shares of NASDAQ:COO opened at $74.02 on Wednesday. The company has a market capitalization of $14.80 billion, a price-to-earnings ratio of 35.93, a P/E/G ratio of 1.79 and a beta of 1.00. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.10 and a quick ratio of 1.23. The business's 50-day moving average is $71.98 and its 200-day moving average is $78.65. The Cooper Companies, Inc. has a 1 year low of $65.00 and a 1 year high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Thursday, May 29th. The medical device company reported $0.96 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.93 by $0.03. The company had revenue of $1 billion for the quarter, compared to the consensus estimate of $995.12 million. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%.The firm's revenue was up 6.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.85 EPS. Cooper Companies has set its FY 2025 guidance at 4.050-4.110 EPS. Equities research analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on COO shares. UBS Group upgraded Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Wells Fargo & Company reduced their price objective on Cooper Companies from $118.00 to $93.00 and set an "overweight" rating on the stock in a research report on Friday, May 30th. Robert W. Baird reduced their price objective on Cooper Companies from $107.00 to $97.00 and set an "outperform" rating on the stock in a research report on Friday, May 30th. BNP Paribas raised Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Finally, BNP Paribas Exane upgraded Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price target on the stock in a research report on Tuesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, Cooper Companies presently has a consensus rating of "Moderate Buy" and an average price target of $96.73.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.